Danon disease is a rare hereditary disorder characterized by progressive skeletal weakness. While there is currently no therapy for Danon disease, researchers are actively exploring numerous therapeutic options. These include pharmacological interventions, aimed at addressing the underlying mechanism of the disease. Clinical trials are ongoing to e